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ABSTRACT 1 
Purpose: To review the methodologies used to assess muscle co-contraction (MCo) with surface 2 
electromyography (sEMG) during gait in people with neurological impairment.  3 
Methods: The Scopus (1995-2013), Web of Science (1970-2013), PubMed (1948-2013) and B-on 4 
(1999-2013) databases were searched. Articles were included when sEMG was used to assess MCo 5 
during gait in people with impairment due to central nervous system disorders (CNS).  6 
Results: Nineteen articles met the inclusion criteria and most studied people with cerebral palsy and 7 
stroke. No consensus was identified for gait assessment protocols (surfaces, speed, distance), sEMG 8 
acquisition (electrodes position), analysis of sEMG data (filters, normalisation techniques) and 9 
quantification of MCo (agonist-antagonist linear envelopes overlapping or agonist-antagonist 10 
overlapping periods of muscles activity, onset delimited).  11 
Conclusion: Given the wide range of methodologies employed, it is not possible to recommend the 12 
most appropriate for assessing MCo. Researchers should adopt recognized standards in future work. 13 
This is needed before consensus about the role that MCo plays in gait impairment in neurological 14 
diseases and its potential as a target for gait rehabilitation can be determined. 15 
  16 
  5 
1. Introduction 17 
 18 
Gait patterns are usually impaired in people with dysfunction of the Central Nervous System (CNS), 19 
such as stroke (Knutsson et al. 1979), traumatic brain injury (Chow et al. 2012), cerebral palsy (Hesse 20 
et al. 2000) or Parkinson´s disease (Dietz et al. 1981). Walking is a very complex function involving 21 
multiple interactions between muscle groups which can be adapted to enable walking at different 22 
speeds or on different surfaces (Winter 2009.). Neurological impairments can generate many 23 
deviations in muscle activity and gait kinematics from those seen in healthy individuals and reduce 24 
the ability to adapt gait appropriately to different environmental conditions. Gait patterns in people 25 
with neurological impairment have been characterized by abnormal muscle co-contraction, especially 26 
when postural stability is challenged (Lamontagne et al. 2000). 27 
Muscle Co-contraction (MCo) is the mechanism that regulates simultaneous activity of agonist and 28 
antagonist muscles crossing the same joint (Busse et al. 2005 ). There is no consensus about the role 29 
that MCo plays in the various stages of recovery after CNS disease. However as MCo has been 30 
demonstrated to be important for providing adequate joint stability, movement accuracy and energy 31 
efficiency (Higginson et al. 2006) and adapting to environmental demands (Darainy et al. 2008), its 32 
importance in neurological recovery is worthy of consideration. 33 
Accurate determination of the impact of neurological impairment on MCo during gait requires robust 34 
measurement techniques which take careful consideration of the environmental conditions under 35 
which gait is assessed (Den Otter et al. 2004). For instance, walking on a ground surface instead of on 36 
a treadmill, walking at different speeds and for longer distances/duration would increase MCo 37 
recruitment and the variability between subjects (Parvataneni et al. 2009; Knarr et al. 2012). The first 38 
research question addressed by this review therefore is: 39 
What are the main characteristics of the gait assessment protocols particularly, the surfaces 40 
where people walked, the speed, distance and time spent walking? Which muscles have been 41 
assessed? 42 
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All measurement techniques, including sEMG, are liable to measurement error which can reduce 43 
validity and reliability and confound interpretation of the findings. MCo assessment during functional 44 
movements, such as walking, requires the analysis of the relative variations in agonist and antagonist 45 
contraction over time using surface electromyography (sEMG) equipment (Fonseca et al. 2001; 46 
Fonseca et al. 2004). Standards have been developed for reporting sEMG signals in different 47 
processing stages, such as the signal acquisition (Surface Electromyography for the Non-Invasive 48 
Assessment Muscles (SENIAM) guidelines), and analogue and digital analysis (International Society 49 
of Electrophysiology and Kinesiology (ISEK) guidelines) (Merletti 1999), but the implementation of 50 
these is variable. Despite these guidelines, controversies remain about the most appropriate techniques 51 
of sEMG signal analysis; (e.g., selection of normalisation technique) leading to inconsistencies across 52 
studies (Burden et al. 2003). Therefore, the second research question this review sought to answer is: 53 
What are the main steps in the acquisition and analysis of the sEMG signals and which 54 
parameters have been considered when quantifying MCo? 55 
A single definition of MCo would also be facilitate interpretation of MCo outcomes during walking. 56 
However MCo has been defined in different ways: the magnitude; the time; or a ratio between the 57 
magnitude and time of simultaneous activation of opposite muscles (Fonseca et al. 2001). As a result 58 
of different definitions, different formulas or computational approaches to quantify MCo have been 59 
employed (Fonseca et al. 2001). All these methodological differences limit the comparison of data 60 
across studies and the understanding of the mechanisms of MCo. The third research question for this 61 
review is therefore: 62 
Which formulas or computational approaches have been used to quantify MCo? 63 
This paper addresses the need to systematically review, synthesize and critique the methodologies 64 
used in this field, contributing to a better understanding of the mechanisms underpinning MCo and of 65 
its role in gait in people with CNS disease.  66 
 67 
2. Methods 68 
2.1. Variable of interest 69 
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The variable of interest in this study was MCo during gait, presented as the time and/or the magnitude 70 
of simultaneous contraction between opposite muscles (Fonseca et al. 2001). 71 
 72 
2.2. Search strategy 73 
The literature search was performed from date of inception until end of November 2012 on the 74 
following databases: Scopus (1995-2013), Web of Science (1970-2013), PubMed (1948-2013) and B-75 
on (1999-2013). B-on includes the Academic Search Complete (EBSCO), Annual Reviews, Elsevier-76 
Science Direct, Nature, Springer Link (Springer/Kluwer), Taylor &Francis and Wiley Online Library 77 
(Wiley). Weekly updates were performed until October 2013.  78 
The following search term (free text words) combinations were used in Pubmed database: co-79 
contraction AND gait, co-contraction AND locomotion, co-contraction AND Walking; co-activation 80 
AND gait; co-activation AND locomotion, co-activation AND walking. Search strategies in the other 81 
databases were derived from Pubmed. The search terms were limited to titles and abstracts. The 82 
reference lists of all studies were also scanned to identify other potentially eligible articles.  83 
The study was conducted using the systematic review method proposed by the Preferred Reporting 84 
Items for Systematic Reviews and Meta-Analysis (PRISMA) (Moher et al. 2009), as shown in Figure 85 
1.  86 
Full papers, written in English or Portuguese that met the following criteria were included if they: (i) 87 
studied gait impairment due to neurological diseases, such as stroke, Parkinson´s disease, cerebral 88 
palsy, traumatic brain injury and other CNS dysfunctions; and ii) analysed MCo during gait of the 89 
lower or upper limb or trunk using sEMG. All articles were independently reviewed by two reviewers 90 
for relevance and quality using PRISMA (Moher et al. 2009). Any discrepancies were resolved 91 
through discussion. 92 
 93 
3. Results 94 
Figure 1 portrays the number of articles identified, the numbers and reasons for exclusion and the total 95 
number of studies included in the final review A descriptive analysis of the methodologies (study 96 
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design; sample; data collection protocol; sEMG data acquisition and analysis and quantification of 97 
MCo) of the included studies is presented in Table 1.  98 
Figure 1: Flow-chart according to the different phases of the systematic review as proposed by PRISMA 99 
 100 
3.1. Study design and sample 101 
Most studies included in this review had observational designs, with the exception of two 102 
experimental studies (Hesse et al. 2000; Massaad et al. 2010). The observational studies assessed 103 
MCo during gait with no intervention or program. From those studies, only one was longitudinal (Den 104 
Otter et al. 2006), with data collection over five time points. The experimental study used non-105 
randomized control groups and assessed gait before and after an intervention (Concato 2004). With 106 
the exception of six articles (Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Detrembleur et 107 
al. 2003; Keefer et al. 2004; Massaad et al. 2010) all others included a group of healthy participants to 108 
provide normative comparison of MCo. MCo during gait was studied in several neurological 109 
conditions including stroke (Knutsson et al. 1979; Hesse et al. 1999; Lamontagne et al. 2000; 110 
Lamontagne et al. 2002; Detrembleur et al. 2003; Den Otter et al. 2006; Den Otter et al. 2007; 111 
Massaad et al. 2010; Chow et al. 2012), cerebral palsy (Leonard et al. 1991; Unithan et al. 1996; 112 
Damiano et al. 2000; Hesse et al. 2000; Keefer et al. 2004; Wakeling et al. 2007; Prosser et al. 2010; 113 
Assumpção et al. 2011), multiple sclerosis and cerebral tumor (Knutsson et al. 1979; Dietz et al. 114 
1981), Parkinson’s disease (Dietz et al. 1981; Arias et al. 2012), traumatic brain injury (TBI) (Chow 115 
et al. 2012) and finally, myelopathy, sclerosis, amyotrophy and meningitis (Dietz et al. 1981).  116 
Sample sizes varied from 5 (Leonard et al. 1991) to 30 participants (Lamontagne et al. 2000). In some 117 
studies, age (Knutsson et al. 1979; Dietz et al. 1981; Den Otter et al. 2006; Den Otter et al. 2007; 118 
Prosser et al. 2010) and gender (Knutsson et al. 1979; Lamontagne et al. 2000; Lamontagne et al. 119 
2002; Prosser et al. 2010) criteria were not well-matched between the group of people with CNS 120 
disorders and the healthy controls. Anthropometric data, including height and weight, were described 121 
in seven studies (Unithan et al. 1996; Damiano et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 122 
2002; Detrembleur et al. 2003; Prosser et al. 2010; Assumpção et al. 2011). The others described 123 
either weight (Hesse et al. 2000) or height (Massaad et al. 2010; Arias et al. 2012). 124 
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3.2. Research Question 1: What are the main characteristics of the gait assessment protocols 125 
particularly, the surfaces where people walked, the speed, distance and time spent walking? 126 
Which muscles were assessed? 127 
Different surfaces were used to assess gait in the included studies. In some studies, a walkway 128 
(usually a corridor on the floor) was used (Knutsson et al. 1979; Damiano et al. 2000; Hesse et al. 129 
2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Keefer et al. 2004; 130 
Wakeling et al. 2007; Assumpção et al. 2011; Arias et al. 2012; Chow et al. 2012), whereas in others 131 
participants walked on a treadmill (Dietz et al. 1981; Leonard et al. 1991; Unithan et al. 1996; Den 132 
Otter et al. 2006; Den Otter et al. 2007; Massaad et al. 2010; Prosser et al. 2010). Gait performance on 133 
a treadmill was compared to gait performance on the ground in one study (Hesse et al. 1999).  134 
A wide variety of instructions were given to participants regarding the speed they should walk. A 135 
number of studies used a free/normal/self-selected speed (Knutsson et al. 1979; Dietz et al. 1981; 136 
Leonard et al. 1991; Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 137 
2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Den Otter et al. 2007; Wakeling et al. 2007; 138 
Massaad et al. 2010; Prosser et al. 2010; Assumpção et al. 2011; Chow et al. 2012). In three studies 139 
subjects were instructed to walk as quickly as possible (Unithan et al. 1996; Hesse et al. 1999; Den 140 
Otter et al. 2006) but only in two of these studies, average gait speeds were reported: 0.27 meters per 141 
second (Hesse et al. 1999); an average of 3 kilometers per hour achieved when asking patients to walk 142 
at 90% of maximum speed during 2 minutes(Unithan et al. 1996). Keefer et al. (Keefer et al. 2004) 143 
asked patients to perform three 5-minute walking trials at 0.67, 0.89 and 1.12 meters per second, 144 
controlled by a treadmill setting. One study (Arias et al. 2012) assessed walking in three different 145 
conditions: subjects were first instructed to walk at their preferred speed, then at fast speed and  146 
finally, to match their steps with a pulsing rhythm provided by a metronome (Arias et al. 2012). 147 
Moreover, in most studies (Knutsson et al. 1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et al. 148 
1999; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; 149 
Detrembleur et al. 2003; Wakeling et al. 2007; Massaad et al. 2010; Prosser et al. 2010; Assumpção et 150 
al. 2011; Arias et al. 2012; Chow et al. 2012) impaired and healthy participants were given the same 151 
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instructions but in 3 other studies (Lamontagne et al. 2000; Lamontagne et al. 2002; Chow et al. 2012) 152 
the healthy participants were asked to walk “very slowly” in an attempt to control for the effect of gait 153 
speed on MCo patterns. 154 
The walking distance or the time spent walking also varied: four studies (Lamontagne et al. 2000; 155 
Hesse et al. 2001; Lamontagne et al. 2002; Detrembleur et al. 2003) asked participants to walk 10 156 
meters and Knutsson et al.(Knutsson et al. 1979) and Chow et al. (Chow et al. 2012) used 5 meters. 157 
Distances longer than 10 meters were also used by Hesse et al. (Hesse et al. 1999), Damiano et al. 158 
(Damiano et al. 2000) and Arias et al. (Arias et al. 2012); whilst the time spent walking was the 159 
criterion used to define the protocol in the other studies, ranging from 40 seconds (at a maximum 160 
speed) (Keefer et al. 2004) to 30 minutes (at a comfortable speed) (Massaad et al. 2010).  161 
MCo was acquired from different muscles during gait performance. Four studies assessed thigh 162 
muscles (Damiano et al. 2000; Keefer et al. 2004; Prosser et al. 2010; Assumpção et al. 2011), five 163 
studies assessed only shank muscles (Dietz et al. 1981; Lamontagne et al. 2000; Lamontagne et al. 164 
2002; Arias et al. 2012; Chow et al. 2012) whilst the others assessed muscles of the entire lower limb. 165 
Only one study assessed MCo from trunk muscles and (Prosser et al. 2010) there were no articles 166 
assessing MCo of the upper limb or any other body structures during gait. 167 
 168 
3.3. Research Question 2: What were the main steps in the acquisition and analysis of the sEMG 169 
signals and which parameters were considered when quantifying MCo? 170 
Data acquisition was inconsistent across studies. Only five studies followed the SENIAM 171 
recommendations for both electrode placement and skin preparation (Detrembleur et al. 2003; Den 172 
Otter et al. 2006; Den Otter et al. 2007; Prosser et al. 2010; Assumpção et al. 2011). Six studies did 173 
not describe electrode position (Dietz et al. 1981; Leonard et al. 1991; Damiano et al. 2000; Hesse et 174 
al. 2000; Wakeling et al. 2007; Massaad et al. 2010); only one of these described how the skin was 175 
prepared (Damiano et al. 2000).  176 
The analogue and digital processing of the sEMG signal was performed differently across studies. 177 
Analogue processing usually involves two main steps:  pre-amplification and application of filters. 178 
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However, two older studies (Knutsson et al. 1979; Dietz et al. 1981) included in this review, used 179 
analogue techniques to construct the linear envelope (LE) of the signal. 180 
Several amplifiers were employed, with different values of common mode rejection ratio and input 181 
impedance, assuming values from 50dB (Chow et al. 2012) to 110dB (Assumpção et al. 2011) and 182 
values from 10KΩ (Unithan et al. 1996; Lamontagne et al. 2000; Lamontagne et al. 2002) to 31MΩ 183 
(Chow et al. 2012) respectively.  184 
Analogue filter characteristics were also different, assuming high-pass cut-off values of 10 Hz 185 
(Unithan et al. 1996), 20Hz (Lamontagne et al. 2000; Lamontagne et al. 2002; Keefer et al. 2004; Den 186 
Otter et al. 2006; Den Otter et al. 2007; Prosser et al. 2010; Arias et al. 2012)or 50 Hz (Leonard et al. 187 
1991) and low-pass cut-off frequencies of 450 Hz (Prosser et al. 2010; Arias et al. 2012), 500 Hz 188 
(Unithan et al. 1996; Den Otter et al. 2006; Den Otter et al. 2007), 800 Hz (Lamontagne et al. 2000; 189 
Lamontagne et al. 2002), 1000Hz (Leonard et al. 1991) or 4000Hz (Keefer et al. 2004). Digital filters 190 
employed in studies also had different low and high cut-off frequencies. Low cut-off frequencies 191 
ranged from 300Hz (Hesse et al. 1999; Detrembleur et al. 2003; Massaad et al. 2010) to 500Hz 192 
(Assumpção et al. 2011; Chow et al. 2012) and high cut-off frequencies ranged from 10 Hz (Hesse et 193 
al. 1999; Lamontagne et al. 2000; Lamontagne et al. 2002; Den Otter et al. 2006; Den Otter et al. 194 
2007; Assumpção et al. 2011; Chow et al. 2012) and 25 Hz (Detrembleur et al. 2003; Massaad et al. 195 
2010).  196 
A LE was digitally constructed in the majority of studies, however a wide range of smoothing 197 
parameters (low-pass filters) were used: 3 Hz (Unithan et al. 1996; Keefer et al. 2004), 6Hz 198 
(Assumpção et al. 2011), 10Hz (Chow et al. 2012), 20Hz (Damiano et al. 2000; Lamontagne et al. 199 
2000; Lamontagne et al. 2002) and 25 Hz (Den Otter et al. 2006; Den Otter et al. 2007).  200 
Normalization is a procedure of referencing EMG data to a standard value, allowing data comparison 201 
between muscles, across time and between subjects (Soderberg et al. 2000; Burden et al. 2003). EMG 202 
signals can be normalized using temporal and amplitude parameters. Different temporal parameters 203 
were used in the included studies: each 5% of gait cycle duration (Knutsson et al. 1979; Dietz et al. 204 
1981); 100% of step cycle duration (Leonard et al. 1991); mean cycle duration and 100% of gait cycle 205 
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duration (Damiano et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 206 
2003; Keefer et al. 2004; Den Otter et al. 2006; Den Otter et al. 2007). Amplitude parameters were 207 
also different across the studies: mean amplitude (Assumpção et al. 2011; Chow et al. 2012) or peak 208 
value (Knutsson et al. 1979; Dietz et al. 1981; Unithan et al. 1996; Arias et al. 2012) in each gait 209 
cycle; mean amplitude of a total of three gait cycles (Keefer et al. 2004); and, mean value or largest 210 
value of maximal voluntary contraction (MVC) (Knutsson et al. 1979; Dietz et al. 1981; Unithan et al. 211 
1996). Lamontagne et al. (Lamontagne et al. 2000; Lamontagne et al. 2002) questioned the value of 212 
normalizing data, claiming that selection of a single maximum value could be affected by electrical 213 
noise and that the muscle activity recorded during maximal voluntary strength could be very different 214 
in healthy subjects and those with stroke. Therefore, these authors did not apply any amplitude 215 
normalization, quantifying MCo using absolute sEMG values. 216 
Several intensity and timing parameters were considered in the analysis of sEMG during gait. The 217 
following intensity parameters were used to analyse the sEMG signal: the peak amplitude in each gait 218 
cycle (Knutsson et al. 1979; Dietz et al. 1981; Lamontagne et al. 2000; Lamontagne et al. 2002), the 219 
area of the envelope (Unithan et al. 1996; Lamontagne et al. 2000; Lamontagne et al. 2002; 220 
Detrembleur et al. 2003; Keefer et al. 2004; Assumpção et al. 2011; Arias et al. 2012; Chow et al. 221 
2012) or a mean value of it (Damiano et al. 2000). Duration of muscle activity depends on accurate 222 
determination of the onset and offset of muscle contraction. Muscle contraction onset is a parameter 223 
used to mark the beginning of muscle activity and it was determined by using various computerized 224 
methods (Unithan et al. 1996; Hesse et al. 2000; Prosser et al. 2010; Chow et al. 2012) or by visual 225 
inspection of the sEMG signal (Detrembleur et al. 2003). Within the computerized methods, Unithan 226 
et al. (Unithan et al. 1996) determined onset when sEMG assume values between 5% and 10% above 227 
the maximum voluntary contraction value; Hesse et al. (Hesse et al. 2000) identified onset as any 228 
significant burst which achieved at least 10% of a maximum sEMG recorded and lasted at least 5% of 229 
a cycle duration; Prosser et al.(Prosser et al. 2010) determined onset periods using a Teager-Kaiser 230 
energy operator, an automatic filtering and de-noising approach; Chow et al.(Chow et al. 2012) 231 
determined onset when the sEMG signal exceeded three standard deviations of the mean. Visual 232 
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inspection, to define muscle onsets, was performed in one study  by two independent raters observing 233 
graphs of previously averaged and normalized sEMG data, (Hesse et al. 1999). A consensus of 234 
opinion between both raters determined the definition of muscle temporal patterns. No information 235 
was provided about the determination of offsets in any of the included papers. 236 
 237 
3.4. Research Question 3: Which formulas or computational approaches have been used to 238 
quantify MCo?  239 
MCo was quantified using different formulas or computational approaches. Two different approaches 240 
were used to quantify the temporal MCo: i) the time of overlap between LE of two opposite muscles 241 
(Unithan et al. 1996; Damiano et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; 242 
Assumpção et al. 2011; Chow et al. 2012) and ii) the time of overlap between activity periods (onset 243 
delimited) of opposite muscles (Knutsson et al. 1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et 244 
al. 1999; Detrembleur et al. 2003; Den Otter et al. 2006; Massaad et al. 2010; Prosser et al. 2010).  245 
To quantify the magnitude of MCo, Hesse et al.(Hesse et al. 2000), Keefer (Keefer et al. 2004) and 246 
Arias et al. (Arias et al. 2012) divided the common area of the LE of antagonist muscles by the sum of 247 
the areas of those muscles. Unitham et al. (Unithan et al. 1996) divided the common area of LE 248 
between two muscles by the number of data points and Assumpção et al.(Assumpção et al. 2011) and 249 
Damiano et al.(Damiano et al. 2000) calculated the difference between the minimum and maximum 250 
values of opposite muscles in each point of the gait cycle. The amount of MCo was also measured 251 
using (i) the mean value of the area of overlap (Damiano et al. 2000), (ii) a correlation between the 252 
spectra of two opposite muscles (Wakeling et al. 2007), (iii) a quantification of the area of overlap 253 
between opposite muscles (Assumpção et al. 2011) or (iv) dividing this area by the overlap duration 254 
(Chow et al. 2012). 255 
 256 
4. Discussion  257 
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This systematic review explored the methodologies used to assess MCo during gait in people with 258 
CNS disorders, that in most cases were stroke and cerebral palsy (Knutsson et al. 1979; Dietz et al. 259 
1981; Leonard et al. 1991; Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et 260 
al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Keefer et al. 2004; Den Otter et al. 2006; 261 
Den Otter et al. 2007; Wakeling et al. 2007; Massaad et al. 2010; Prosser et al. 2010; Assumpção et 262 
al. 2011; Chow et al. 2012). Given the considerable variability in the methods used to assess gait, 263 
analyse sEMG and quantify MCo, no recommendations can be made at this time about the most 264 
appropriate methodologies to assess MCo during gait in people with CNS disorders. 265 
Several differences were found in the gait protocols of the included studies, including the walking 266 
speed, ground surface and duration or the distance that people walked. Walking speed is known to 267 
influence muscle activity in both healthy people and those with impairment (Hesse et al. 2001). In the 268 
majority of studies, participants were instructed to walk at their self-selected speed (Knutsson et al. 269 
1979; Dietz et al. 1981; Leonard et al. 1991; Hesse et al. 1999; Damiano et al. 2000; Hesse et al. 270 
2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Wakeling et al. 271 
2007; Massaad et al. 2010; Prosser et al. 2010; Assumpção et al. 2011; Chow et al. 2012). However, 272 
as the self-selected speed of healthy subjects is obviously different from those with CNS disorders, 273 
some authors (Lamontagne et al. 2000; Lamontagne et al. 2002; Chow et al. 2012) tried to control for 274 
the influence of speed on gait pattern and match data capture conditions by instructing controls to 275 
walk at a very slow speed. However, subjects are walking under unusual circumstances which may 276 
increase postural instability (Den Otter et al. 2004) and may cause different muscle activity bursts 277 
(Lingling et al. 2010). This may not therefore be the most appropriate methodology for defining speed 278 
during gait. Self-selected gait speed for both healthy people and people with CNS disorders might be 279 
the most accurate methodology for comparing sEMG data.  280 
Ground surface is also known to influence muscle activity. In subjects with stroke, there is a tendency 281 
to increase cadence and to induce muscle activity modifications (e.g., earlier muscle contraction 282 
onset) during treadmill walking, compared with walking on the ground (Harris-Love et al. 2004). This 283 
makes comparison between the results obtained in ground walking (Knutsson et al. 1979; Dietz et al. 284 
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1981; Damiano et al. 2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; 285 
Detrembleur et al. 2003; Keefer et al. 2004; Wakeling et al. 2007; Assumpção et al. 2011; Chow et al. 286 
2012) and treadmill walking very difficult (Dietz et al. 1981; Leonard et al. 1991; Unithan et al. 1996; 287 
Den Otter et al. 2006; Massaad et al. 2010; Prosser et al. 2010). There are, however, practical reasons 288 
why the different surfaces may have been selected for use with people with CNS disorders. Treadmill 289 
walking offers a more restricted space, protective bars and better monitoring conditions to enhance 290 
safety in people with poor balance (Laufer et al. 2001). However, studies using ground walking are 291 
more reflective of everyday life and may be easier and cheaper to conduct. A validation study 292 
exploring what incline grade a treadmill should be at to more closely replicate walking on a ground 293 
surface (Laufer et al. 2001; Mason et al. 2013) would be a useful future step.  294 
Subjects with CNS disorders tend to increase their MCo magnitude to be able to walk longer or 295 
further, resulting in inefficient MCo strategies and abnormal walking patterns and potentially 296 
contributing to fatigue and muscle pain (Dean et al. 2001; Brunner et al. 2008).Recommendations to 297 
the most appropriate walking distance or time for use in sEMG studies are therefore needed. 298 
Despite publication of the SENIAM guidelines for sensor placement procedures in 1996 (Hermens et 299 
al. 2000) and of ISEK guidelines for reporting sEMG data acquisition (Merletti 1999) and signal 300 
analysis in 1999, many studies in this review did not adhere to the recommendations nor offer 301 
justification for their lack of adherence. The fulfillment of these guidelines is determinant for the 302 
analysis of MCo, as it affects the characteristics of the sEMG signal recorded from opposite muscles 303 
(Fonseca et al. 2001).  304 
In terms of sensor placement, the first study from this review to follow these guidelines was from 305 
2003 (Detrembleur et al. 2003) but a further five later studies (Keefer et al. 2004; Wakeling et al. 306 
2007; Massaad et al. 2010; Arias et al. 2012; Chow et al. 2012) did not follow the SENIAM 307 
acquisition recommendations.  308 
In terms of signal processing analysis, the use of bandwidth amplifier filters within the range of 5 Hz 309 
to 500 Hz and the use of low pass filters at 5 or 6Hz to smooth the full-wave rectified signal, 310 
constructing a LE (Merletti 1999) were important ISEK recommendations. However, most studies in 311 
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this review used amplifier filters with characteristics different from those recommended (Merletti 312 
1999), high-pass cut-offs at 20Hz (Lamontagne et al. 2000; Lamontagne et al. 2002; Keefer et al. 313 
2004; Den Otter et al. 2006; Den Otter et al. 2007; Prosser et al. 2010) and low-pass cut-offs varied 314 
from 4000Hz (Keefer et al. 2004) to450Hz (Prosser et al. 2010) Only Assumpção et al. (Assumpção et 315 
al. 2011) used a 6Hz low-pass filter to construct a LE, following the recommendations (Merletti 316 
1999). Differences in sEMG data acquisition and analysis of the included studies hinder the 317 
comparison of results across studies, therefore future research should strictly adhere to the SENIAM 318 
and ISEK recommendations or be able to offer a scientific justification for non-adherence. 319 
There are no guidelines for the most adequate procedures for normalizing sEMG signal during gait 320 
(Burden et al. 2003). Temporal normalization was the most commonly used procedure in the included 321 
studies (Dietz et al. 1981; Hesse et al. 2000; Lamontagne et al. 2000; Detrembleur et al. 2003; 322 
Massaad et al. 2010; Assumpção et al. 2011). Temporal normalization involves defining a reference 323 
time period (e.g., each 5% of gait cycle) to enable comparison between individuals, across muscles or 324 
between trials. The use of temporal normalization alone, in the absence of any other method of 325 
normalization, has been criticized because it ignores the relative amplitude of the signal, potentially 326 
resulting in signals of inappropriate amplitudes being considered as normal (Bogey et al. 1992). 327 
Determining the most appropriate method for normalizing sEMG amplitude is controversial. The aim 328 
of this procedure is to express the activity between muscles, across time and between individuals in 329 
relation to a reference value obtained during standard and reproducible conditions (Burden et al. 330 
1999). Three studies recorded reference values during maximum isometric voluntary contraction 331 
(MVC) (Dietz et al. 1981; Unithan et al. 1996; Damiano et al. 2000); however, in patients with 332 
neurological conditions, this may not represent the maximum activation capacity of the muscle, 333 
resulting in increased inter-subject variation (Burden et al. 1999). The mean ensemble value (mean 334 
value reached within a period) was used in three other studies (Keefer et al. 2004; Assumpção et al. 335 
2011; Chow et al. 2012). Mean ensemble value and peak ensemble value (maximum value reached 336 
within a period), have both been considered feasible methods for normalizing data from neurological 337 
patients (Yang et al. 1984). These methods consist of dividing each sEMG data point by the mean or 338 
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the peak value recorded from the same sEMG portion of data (Burden et al. 2003). These are more 339 
reliable methods as they have the capacity to reduce inter-subject variability(Yang et al. 1984).  340 
The area of overlap between the LE of opposite muscles was used in eight studies (Damiano et al. 341 
2000; Hesse et al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Keefer et al. 2004; 342 
Assumpção et al. 2011; Arias et al. 2012; Chow et al. 2012) to achieve a value of time or intensity of 343 
MCo during gait. The mean value of overlap could also be an important parameter for quantifying 344 
MCo (Damiano et al. 2000). An index based on the area of overlap between the LE of two opposing 345 
muscles in a specific time window was used in two studies (Unithan et al. 1996; Chow et al. 2012). A 346 
LE is a linear distribution of amplitudes at each gait cycle interval proposed (Shiavi et al. 1998) as a 347 
good method for studying synergy patterns during gait. However, various factors in the EMG 348 
measurement process might influence the establishment of representative LE´s profiles, such as 349 
electrode location, thickness of subcutaneous tissues or the system used to detect the signal (Farina et 350 
al. 2004) and therefore using amplitude parameters for comparative purposes has been criticised 351 
(Farina et al. 2004). LE repeatability can be improved by precision in electrode placement and skin 352 
preparation and by following recommendations for sEMG signal analysis (Arsenault et al. 1986; 353 
Shiavi et al. 1998): between six and ten strides , depending on the variability of each muscle assessed 354 
and an envelope filter with a cut-off frequency 8.9 Hz are recommended. However some authors 355 
(Morey-Klapsing et al. 2004; Raez et al. 2006) remain critical of the use of amplitude parameters for 356 
inter-subject comparison. 357 
An alternative method used to quantify MCo in the studies in this review, was the estimation of time 358 
during which opposing muscles are active (Knutsson et al. 1979; Dietz et al. 1981; Shiavi et al. 1998; 359 
Detrembleur et al. 2003; Den Otter et al. 2006; Massaad et al. 2010; Prosser et al. 2010). This method 360 
depends on the accuracy of the process used to detect muscle contraction onset (Kerem et al. 2010). 361 
At least three different processes have been used: visual inspection, threshold computation and 362 
automated algorithms (Kerem et al. 2010). Variability within the automatic methods has also been 363 
found as both simple (intensity) (Unithan et al. 1996; Chow et al. 2012) and double (time and 364 
intensity) (Hesse et al. 2000) threshold methods have been used. Double-threshold methods have 365 
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some potential to eliminate false positives or delayed onset detection, however the establishment of 366 
thresholds were inconsistent across studies (Staude et al. 2001). This variability hinders the 367 
comparison of temporal MCo patterns and therefore a consensus on temporal automatic methods is 368 
needed, improving the sensitivity of the thresholds to the signal parameters. 369 
The variability found in the methods used to estimate MCo and the lack of reliability of sEMG 370 
intensity parameters makes it difficult to compare MCo patterns between studies. Further research 371 
should therefore follow guidelines for sEMG data acquisition and analysis and reach a consensus on 372 
the temporal MCo estimation. 373 
 374 
5. Limitations  375 
This review was limited to studies investigating gait in people with neurological impairment in order 376 
to minimize methodological variability which would occur due to the specific requirements of 377 
different populations (Burden et al. 2003). However, further reviews on MCo during gait in other 378 
disorders such as osteoarticular (Heiden et al. 2009), ligament (Chmielewski et al. 2005) or 379 
developmental disorders (Gontijo et al. 2008) are still required. Such reviews may facilitate the 380 
generation of methodological consensus across a range of conditions. In addition, only articles written 381 
in Portuguese and English were included in this systematic review narrowing the number of eligible 382 
articles.  383 
 384 
6. Conclusion 385 
A systematic review was undertaken to review the literature concerning the methodologies used for 386 
measuring MCo during gait in people with neurological impairment due to CNS disorders. 387 
It was not possible to make recommendations about the most appropriate methodologies for assessing 388 
MCo during gait in people with CNS disorders because of the considerable range of gait protocols and 389 
methods for the acquisition, analysis of sEMG and quantification of MCo. The area of overlap 390 
between the LE of opposite muscles and also the estimation of onset-delimited temporal MCo offer 391 
potential as methods for quantifying MCo. However, for improving repeatability of MCo outcomes 392 
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methodological criteria for sEMG data collection must be fulfilled and the automatic methods for 393 
determining double-thresholds validated.  394 
Given that MCo is being considered as a potential parameter to target in gait rehabilitation (Den Otter 395 
et al. 2006) more robust standardized methods of evaluation and a rigorous adherence to SENIAM 396 
and ISEK guidelines are required. 397 
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305 records after removing duplicates.  
34 full-text articles were assessed for 
eligibility. 15 full-text articles were excluded due to 
methodological reasons: 
- did not assess the muscle co-contraction 




















17 articles were identified through other 
sources. 
422 abstracts were excluded: 
- did not assess people with CNS disorders; 
- the main theme was unrelated with muscle 






Sample Protocol to 
assess Walking 
EMG acquisition EMG analysis  MCo quantification  Assessed Muscles          
Electrodes location/ 
Skin preparation 















Walking along 5 
meters; 
At free speed; 
Hip abductor: 3cm apart on a 
line perpendicular to middle 
fibers, mid away between 
trochanter major and 
punctum coxae; 
Hip adductor: electrodes 5 
cm apart on a line betwenn 
arcus pubis and epicondylus 
tibialis of femur ate the 
proximal third of the tigh; 
(…) 
1)Pre-amplifier a.c. (high-pass); 
2)Envelope: Rectification 
Low pass filter at 1 Hz; 
1)Normalised to the peak 
amplitude in each gait 
cycle; 
2)Normalised to 5% of 
each gait cycle duration; 
Time of antagonists 
muscles overlap/ each 5% 






















Walking on a 
treadmill; 
Walk as normal 
as possible, at 
least at 
2km/hour; 
Not described; 1)Envelope: Rectification 
Low pass filter at 50Hz; 
1)Smoothed digitally; 
2)Normalised to 5% of 
each gait cycle duration; 
3) Normalised to mean 
value during maximum 
voluntary contraction; 
Time of antagonists 
muscle activation/interval 

















walking with (n=2) 





Walking on a 
treadmill at a 
comfortable 
speed; 
Not described; 1)Filter: 
High pass 50Hz 
Low pass 1000Hz; 
1)Temporally normalized 
to 100% of step duration; 
Time % antagonists 




















Walking on a 
treadmill with 





Placed in pairs, 
interelectrode spacing of 4 
cm: over vastus lateralis, 
middle of the hamstrings 
group, tiabilais anterior and 
soleus; 
Skin preparation: shaving, 
1)Pre-amplifier CMRR10MΩ; 
2)Filter: 
High pass: 10Hz; 




2)Normalised to the 
largest value observed in 
each muscle  
OR to MVC; 
Index=Area of envelope 
overlapping between, 








Table 1: Descriptive analysis of the studies included on this systematic review. (EMG) electromyography; (MCo) Muscle co-contraction; (MVC) maximum voluntary contraction; CMRR, common mode rejection ration, RMS, 






At 3km/h and 
90% of maximum 
speed; 
abrading and cleaning with 
alcohol; 
3) Onset: sEMG assume 
values between 5% and 
10% above the maximum 
voluntary contraction 
value; 
Offset: not clear defined; 
Hesse, 
Konrad, 









with 15% of BWS, 
with 30% of 
BWS) and floor 
walking (15 
meters). 
Mean of velocity 
= 0,27m/s; 




preparation;   
1)Pre-amplifier; 1)Filter: 
Low-pass at 300 Hz; 
High-pass at 10 Hz; 
2)Rectification; 
3)Temporally normalized 
to the mean cycle 
duration; 
4) Onset: two 
independent raters 
observing graphs of 
previously averaged and 
normalized sEMG data; 
Offset: not clear defined; 
1)Amount of 
simultaneously activity 
between two antagonists 
muscles; 
2)Time of simultaneously 




Tibialis Anterior  
Medial 
Gastrocnemius  
Biceps Femoris  
Vastus Latrealis  
Gluteus Medius  
Erector spinae  
Non affected side:  
Tibialis Anterior  
Gastrocnemius  














(twice), at their 
selected speed; 
Not described; 1)Pre-amplifier; 1)Temporally normalised 
to the mean cycle 
duration; 
2) Onset: significant burst 
which achieved at least 
10% of a maximum sEMG 
recorded and lasted at 
least 5% of a cycle 
duration; 
Offset: not clear defined; 
Index =[(2 x common area 






















Walk for 10 
meters; 
Subjects with 




walk for very 
slow speed; 
 
Longitudinal placed 1 cm 
apart over the upper third of 
the tibialis anterior; over the 
belly of medial 
gastrocnemius; 
 
Skin preparation: Rubbed 
with alcohol;  
1)Pre-amplifiers: input impedance of 
10MΩ, CMRR of 93dB; 
2)Filter: 
High-pass at 20 Hz; 
Low-pass at 800Hz; 
1)High-pass Butterworth 
at 10Hz; 
2)Linear Envelope:  
Rectification; 
Smoothing using a 20Hz 
low-pass filter; 
3)Normalised to 100% of 
gait cycle; 
Temporal Index: dividing 
the time of overlap 
between agonist and 
antagonist (over a 
threshold of 20µV) by the 
duration of the gait phase; 
averaging coactivation 

























Skin preparation: Rubbed 
with alcohol; 
 1)Linear envelope: 
Low-pass RMS filter at 
5Hz; 
Low-pass RMS filter at 
15Hz; 
2)Normalised to MVC; 
Mean value of the area of 
overlap (the EMG 
minimum) of the linear 
envelopes of the two 
muscles EMG signal;  
Index = the minimal EMG 
value / maximal EMG 
















Walk along 10 
meters; 
Subjects with 
stroke: at natural 
speed;  
Healthy subjects: 
natural and very 
slow speed;  
 
Longitudinal placed 1 cm 
apart over the upper third of 
the tibialis anterior; over the 
belly of medial 
gastrocnemius; 
 
Skin preparation: Rubbed 
with alcohol; 
1)Pre-amplifiers: input impedance of 
10MΩ, CMRR of 93dB; 
2)Filter: 
High-pass at 20 Hz; 
Low-pass at 800Hz; 
1)High-pass Butterworth 
at 10Hz; 
2)Linear Envelope:  
Rectification; 
Smoothing using a 20Hz 
low-pass filter; 
3)Normalised to 100% of 
gait cycle; 
Temporal Index = time 
during which an 
overlapping surface 
(threshold of 20 µV ) of 
GAS and TA/ in each gait 
phase of interest; 
Co-contraction was 












Walk across 10 
meters; 
At a comfortable 
speed; 
SENIAM recommendations 
for electrodes placement and 
skin preparation; 
 1)Rectification; 
2)Filters: High-pass at 
25Hz+ 
low-pass at-300Hz; 
2)Normalised to 100% in 
time of gait cycle; 
Temporal Index = % of gait 
cycle during which the 


















walking trials at: 
0.67, 0.89 and 
1.12 m/s;. 
Halfway between the mid-
portion and distal end of the 
muscle; fastened with 
double-sided; 
A single reference electrode 
was placed over distal ulna; 
 
Skin preparation: shaved, 
abraded, cleaned with 
alcohol; 
1)Pre-amplifiers: CMRR of 87dB at 
60Hz; 
2) Filter: 
High-pass at 20 Hz; 




second order zero-lag 
Butterworth at 3 Hz; 
2)Normalised to 100% in 
time of gait cycle; 
3)Normalised to ensemble 
average for each muscle 
of three gait cycles; 
Index= 2x[common area 
between agonist and 
antagonist/area of 
ag.+area of ant.]x100; 















Walking on a 
treadmill: as 
early as possible 
after admission; 






for electrodes placement and 
skin preparation; 
1)Pre-amplifiers: noise level of 1µV, 
CMRR >95db;  
2)Filter: 
High-pass 3rd order Butterworth (-
3db, at 20Hz); 
Low pass 2nd order Butterworth filter 
(-3db, at 500Hz); 
1)High pass filter at 10Hz; 
2)Envelope: 
Rectification 
Low pass filter at 25Hz; 
3)Normalised to 100% in 
time of gait cycle; 
Relative amount of time 
that two muscles were 
simultaneously active 











speed as much as 
possible; 
Den Otter et 
al., 2007(Den 
Otter, Geurts 
et al. 2007) 










Walking on a 




for electrodes placement and 
skin preparation; 
1)Pre-amplifiers: noise level of 1µV, 
CMRR >95db;  
2)Filter: 
High-pass 3rd order Butterworth (-
3db, at 20Hz); 
Low pass 2nd order Butterworth filter 
(-3db, at 500Hz); 
1)High pass filter at 10Hz; 
2)Envelope: 
Rectification 
Low pass filter at 25Hz; 
3)Normalised to 100% in 
time of gait cycle; 
Relative amount of time 
that two muscles were 
simultaneously active 



























 1)Wavelet analysis; 
2)Intensity spectrum; 
Correlation spectra 
between two antagonists 
muscles; 

















- 30 minutes 
walking in a 
treadmill with 
feedback of the 
CM displacement 








Not described;  1)Filter: 
High pass at 25 Hz; 
Low pass at 300Hz; 
2)Rectification; 
3)Normalised to 100% in 
time of gait cycle; 
Index: temporal 
quantified as the % of 
stride during which these 
































for electrodes placement and 
skin preparation; 
1)Pre-amplifier: gain of 10; 
2)Filter: 
High pass at 20Hz; 
Low pass at 450Hz; 
1) Filter: 
Low-pass Butterworth of 
2nd order at 10Hz; 
2) Onset: using a Teager-
Kaiser energy operator, an 
automatic filtering and de-
noising approach; 



























Walk along a 






for electrodes placement and 
skin preparation; 
1)Pre-amplifier: CMRR of 110dB; 1)High-pass filter at 10Hz; 
2)Low-pass filter at 500Hz; 
3) Linear Envelope: 
Rectification 
Smoothing with filter at 6 
Hz; 
4)Normalised to the 
averaged amplitude of 
each muscle over the 
entire gait cycle; 
Index = minimum 
EMG/Maximum 
EMG/each point of the 
gait cycle; (averaged over 
5 gait cycles).  
Magnitude: overlap of the 



















Gender and age 
matched; 




Walking 7 meters 
(8-10 times); 
Stroke and TBI 




at a self-selected 
very slow speed; 
Cram and Kasman 
recommendations (1998) for 
electrodes placement and 
skin preparation; 
1)Pre-amplifier: input impedance of 
31KΩ, CMRR >50dB; 
1)Filter: 
High pass at 10Hz; 
Low pass at 500Hz; 
2)Linear envelope: 
Rectification; 
Smoothing with low-pass 
2nd order Butterworth at 
10Hz; 
3)Normalised to the 
averaged amplitude of 
each muscle over the 
entire gait cycle: 
4) Onset: sEMG signal 
exceeded three standard 
deviations of the mean; 
Offset: not clear defined; 
Index = area of agonist-
antagonist 
muscles/overlap duration; 
Duration = duration of 






















Walking 6m long 
until 24m is 
completed: 
 
Walk at their 
preferred speed; 
 




their steps to a 
metronome; 
 
Cram and Kasman 
recommendations (1998) for 
electrodes placement and ; 
 
Skin preparation: shaved, 
abraded and cleaned with 
alcohol; 
1) Pre-amplifier: gain 1000; 




2) Averaging time 
constant of 10ms; 
3) Normalised by the peak 
amplitude during baseline 
gait; 
Index= the amount of 
overlapping activity /sum 
of both areas; 
Tibialis Anterior 
Soleus 
